^
Association details:
Biomarker:miR-186 overexpression
Cancer:Breast Cancer
Drug:paclitaxel (Tubulin inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Title:

Resistance of breast cancer cells to paclitaxel is associated with low expressions of miRNA-186 and miRNA-7

Published date:
09/01/2023
Excerpt:
miR-186 and miR-7 expression in BC tissues was higher in patients with better outcomes of PTX-based neoadjuvant therapy....In conclusion, presented results showed that miR-185 and miR-7 expressions are higher in PTX-sensitive BC cells than in resistant cells. It was demonstrated for the first time that the overexpression of these molecules in BC tissues is associated with sensitivity to PTX...
DOI:
http://dx.doi.org/10.20517/cdr.2023.19